Core Insights - WORK Medical Technology Group LTD has entered into a significant service agreement with GemPharmatech Corporation, marking a pivotal shift in its strategy towards research and development execution [1][5] - Neologics Bioscience Inc., a subsidiary of WORK Medical, will provide various testing services to GemPharmatech for a total payment of US$114,000 [2] - The partnership is expected to accelerate Neologics' business development and reinforce WORK Medical's strategic diversification [5] Company Overview - WORK Medical is a supplier of medical devices in China, developing and manufacturing Class I and II medical devices, with a diverse product portfolio of 21 products sold in 34 provincial-level regions in China and over 30 countries globally [6] - The company has received multiple quality-related manufacturing designations and has registered 17 products with the U.S. FDA, allowing entry into the U.S. market [6] Neologics Bioscience Inc. - Neologics specializes in R&D services and operates a laboratory and R&D center in San Diego, California, focusing on collaborations with universities, hospitals, and biotechnology firms [3] - The company aims to develop systematic solutions for drug screening and preclinical validation through an independent R&D platform [3] - WORK Medical has invested US$1 million in Neologics, acquiring a 10% equity interest [3] GemPharmatech Corporation - GemPharmatech is a leading contract research organization providing genetically engineered mouse models and preclinical research services [4] - The company specializes in advanced animal models using gene-editing technologies and offers a comprehensive suite of services including mouse model customization and drug efficacy evaluation [4]

Core Insights - WORK Medical Technology Group LTD has entered into a significant service agreement with GemPharmatech Corporation, marking a pivotal shift in its strategy towards research and development execution [1][5] - Neologics Bioscience Inc., a subsidiary of WORK Medical, will provide various testing services to GemPharmatech for a total payment of US$114,000 [2] - The partnership is expected to accelerate Neologics' business development and reinforce WORK Medical's strategic diversification [5] Company Overview - WORK Medical is a supplier of medical devices in China, developing and manufacturing Class I and II medical devices, with a diverse product portfolio of 21 products sold in 34 provincial-level regions in China and over 30 countries globally [6] - The company has received multiple quality-related manufacturing designations and has registered 17 products with the U.S. FDA, allowing entry into the U.S. market [6] Neologics Bioscience Inc. - Neologics specializes in R&D services, focusing on collaborations with universities, hospitals, and biotechnology firms, and operates a laboratory and R&D center in San Diego, California [3] - The company aims to develop systematic solutions for drug screening and preclinical validation through an independent R&D platform [3] GemPharmatech Corporation - GemPharmatech is a leading contract research organization providing genetically engineered mouse models and preclinical research services, utilizing advanced gene-editing technologies [4] - The company offers a comprehensive suite of services, including mouse model customization and drug efficacy evaluation [4]